Clinical Trials Directory

Trials / Completed

CompletedNCT04773834

Evaluation of an Automated Physician-Directed Messaging on Patient Engagement in the Digital Diabetes Prevention Program

A Randomized Control Trial to Study the Effects of Automated Physician Directed Messaging on Patient Engagement in a Digital Diabetes Prevention Program

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
551 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

This study aims to understand the effects of automated physician directed messaging on patient engagement in the digital diabetes prevention program (dDPP). The messages are tailored to patient engagement levels based on established engagement thresholds, which are based on the patient's use of the dDPP application. The system is designed to minimize work for providers by sending automated targeted messages to patients to potentially increase engagement, prevent onset of diabetes and improve clinical outcomes. The patients in the study are automatically nudged using a combination of text messaging and MyChart messaging.

Detailed description

Using a mixed-methods design, this study will be completed in three phases. For Phase 3, we aim to conduct a randomized control trial with 400 patients with pre-diabetic, all of whom will be using the dDPP application. Half of enrolled patients will be randomized to the intervention group and receive automated targeted messaging.

Conditions

Interventions

TypeNameDescription
OTHERDigital diabetes prevention program (dDPP)The digital diabetes prevention program is through the Noom app, and the three devices (Fitbit physical activity tracker, Fitbit weight scale, and self-check hemoglobin a1c kit). This is a one year diabetes prevention program where participants will be expected to participate in 5 to 7 interviews over a 18 month period.
OTHERAdapted dDPP-EHR toolThis is a product of Phase 1 and 2 of this study where participants will receive detailed text messaging regarding their engagement levels in Noom app.

Timeline

Start date
2021-02-01
Primary completion
2025-01-15
Completion
2025-06-01
First posted
2021-02-26
Last updated
2026-03-03
Results posted
2026-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04773834. Inclusion in this directory is not an endorsement.